Literature DB >> 30536167

Inflammasomes in CNS Diseases.

Eduardo A Albornoz1, Trent M Woodruff1, Richard Gordon2,3.   

Abstract

Neuroinflammation is a common pathological feature in almost all neurological diseases and is a response triggered as a consequence of the chronic activation of the innate immune response in the CNS against a variety of stimuli, including infection, traumatic brain injury, toxic metabolites, aggregated proteins, or autoimmunity. Crucial mediators of this neurinflammatory process are the intracellular protein complexes known as inflammasomes which can be triggered by pathogens as well as pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). However, chronic inflammasome activation can eventually result in cellular death and tissue damage, leading to the release of DAMPs that can reactivate the inflammasome, thereby propagating a vicious cycle of inflammation. The primary cells involved in CNS inflammasome activation are the immunocompetent microglia and the infiltrating macrophages into the CNS. However, astrocytes and neurons also express inflammasomes, and the understanding of how they are engaged in the pathogenesis of a variety of neurological diseases is crucial to develop effective therapeutic approaches for CNS pathologies that are propagated by chronic inflammasome activation. This chapter covers the activation mechanisms of relevant inflammasomes in the brain and summarizes their roles in the pathogenesis and progression of different neurological conditions.

Entities:  

Keywords:  ASC; IL-1β; Inflammasome; Microglia; NLRP3; Neurodegeneration; Neuroinflammation

Mesh:

Substances:

Year:  2018        PMID: 30536167     DOI: 10.1007/978-3-319-89390-7_3

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  11 in total

Review 1.  Resveratrol Can Attenuate Astrocyte Activation to Treat Spinal Cord Injury by Inhibiting Inflammatory Responses.

Authors:  Ruihua Fan; Yong Zhang; Benson O A Botchway; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2021-08-19       Impact factor: 5.590

2.  Altered inflammasome machinery as a key player in the perpetuation of Rett syndrome oxinflammation.

Authors:  Alessandra Pecorelli; Valeria Cordone; Nicolò Messano; Changqing Zhang; Stefano Falone; Fernanda Amicarelli; Joussef Hayek; Giuseppe Valacchi
Journal:  Redox Biol       Date:  2019-10-06       Impact factor: 11.799

Review 3.  Can We Treat Neuroinflammation in Alzheimer's Disease?

Authors:  Sandra Sánchez-Sarasúa; Iván Fernández-Pérez; Verónica Espinosa-Fernández; Ana María Sánchez-Pérez; Juan Carlos Ledesma
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

4.  Pomelo peel oil alleviates cerebral NLRP3 inflammasome activation in a cardiopulmonary resuscitation rat model.

Authors:  Xin-Sen Zou; Lu Xie; Wen-Yan Wang; Gao-Yang Zhao; Xin-Yue Tian; Meng-Hua Chen
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

5.  Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.

Authors:  Juan Luis Sanchez-Sanchez; Kelly V Giudici; Sophie Guyonnet; Julien Delrieu; Yan Li; Randall J Bateman; Angelo Parini; Bruno Vellas; Philipe de Souto Barreto
Journal:  Alzheimers Res Ther       Date:  2022-01-07       Impact factor: 6.982

6.  Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice.

Authors:  Guohua Li; Yu Wang; Fang Cao; Dawei Wang; Limin Zhou; Yanwu Jin
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

7.  Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model.

Authors:  Haoyun Zhang; Hao Li; Bingkun Huang; Shaoye Wang; Ying Gao; Fandi Meng; Yanchun Chen; Fenghua Zhou; Yingjun Guan; Xin Wang
Journal:  BMC Neurosci       Date:  2022-08-09       Impact factor: 3.264

8.  Chromone derivatives suppress neuroinflammation and improve mitochondrial function in the sporadic form of Alzheimer's disease under experimental conditions.

Authors:  Dmitry I Pozdnyakov; Denis S Zolotych; Viktoriya M Rukovitsyna; Eduard T Oganesyan
Journal:  Iran J Basic Med Sci       Date:  2022-07       Impact factor: 2.532

Review 9.  The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.

Authors:  Fangzhou Jiao; Zuojiong Gong
Journal:  Oxid Med Cell Longev       Date:  2020-09-14       Impact factor: 6.543

10.  Ability of Post-treatment Glycyrrhizic Acid to Mitigate Cerebral Ischemia/Reperfusion Injury in Diabetic Mice.

Authors:  Yuan Li; Na Yao; Ting Zhang; Fengying Guo; Xiangying Niu; Zhihui Wu; Shaozhang Hou
Journal:  Med Sci Monit       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.